Related Experiment Video

Updated: Aug 12, 2026

Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection
11:13

Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection

Published on: March 28, 2012

Biochemical basis of aminoglycoside ototoxicity

J Schacht1

  • 1Kresge Hearing Research Institute, University of Michigan School of Medicine, Ann Arbor.

Otolaryngologic Clinics of North America
|October 1, 1993
PubMed

Insights

Aminoglycoside toxicity stems from calcium antagonism and ion channel blockade acutely, and requires metabolism for chronic effects. Understanding the toxic metabolite and glutathione

Area of Science:

  • Pharmacology
  • Toxicology
  • Molecular Biology

Background:

  • Aminoglycoside antibiotics are crucial for treating bacterial infections, but their use is limited by significant toxicities, including ototoxicity and nephrotoxicity.
  • The precise molecular mechanisms underlying aminoglycoside-induced toxicity remain incompletely understood, hindering the development of safer alternatives.
  • The decreasing clinical utility of aminoglycosides due to bacterial resistance and the availability of alternative antibiotics necessitates a deeper understanding of their adverse effects.

Purpose of the Study:

  • To elucidate the molecular basis of aminoglycoside toxicity, differentiating between acute and chronic mechanisms.
  • To investigate the role of drug metabolism in tissue-specific toxicity and explore potential detoxification pathways.
  • To propose a unified hypothesis for aminoglycoside action and toxicity, integrating existing knowledge with new findings.

Main Methods:

  • Analysis of acute drug effects, focusing on calcium antagonism and ion channel blockade.
  • Investigation of the metabolic pathways involved in chronic aminoglycoside toxicity.
  • Exploration of the potential role of glutathione in modulating toxin formation and detoxification.

Main Results:

  • Acute aminoglycoside toxicity is primarily mediated by calcium antagonism and ion channel blockade.
  • Chronic toxicity is dependent on drug metabolism, with tissue-specific effects determined by the balance between toxin synthesis and detoxification.
  • Glutathione shows potential in blocking toxin formation or enhancing detoxification, suggesting a role in preventing aminoglycoside-induced ototoxicity.

Conclusions:

  • A rational explanation for aminoglycoside toxicity is emerging, distinguishing between acute and chronic mechanisms.
  • Understanding the toxic metabolite and its interaction with cellular processes is key to developing safer aminoglycosides.
  • Targeting metabolic pathways and detoxification mechanisms, potentially involving glutathione, may offer strategies to mitigate aminoglycoside-induced ototoxicity and nephrotoxicity.

More Related Videos

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration12:21

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration

Published on: November 26, 2015

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Related Concept Videos

Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...